AI and Autonomy Alibaba Group gets FDA nod for cancer detection tool The tool can effectively detect early-stage cancers in asymptomatic patients Joseph MortonApril 24, 2025
AI and Autonomy Ainos introduces breath sensing equipment to robots in Japan System digitizes and identifies a wide range of volatile organic compounds (VOC), which are compiled into a SmellID Joseph MortonApril 23, 2025
Medical and Pharmaceutical Alarming CT radiation study highlights need for alternative diagnostic tools University of California researchers have determined that these machines can cause 1 out of every 20 new cancer cases Rowan DunneApril 15, 2025
Medical and Pharmaceutical How could a simple blood test could eliminate tumour biopsies? The company has received support from the Centre of Expertise in Advanced Materials and Sustainability and Innovate UK Joseph MortonApril 15, 2025
Medical and Pharmaceutical Median Technologies clears hurdle on the way to regulatory acceptance in EU and US The company has met a key requirement for regulatory submissions in the US and Europe Joseph MortonApril 3, 2025
Medical and Pharmaceutical Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment Relacorilant is designed to address disorders linked to the stress hormone cortisol Joseph MortonMarch 31, 2025
Medical and Pharmaceutical South Korean research institution develops lung cancer breath test with 95% accuracy It uses a machine with 70 sensors to detect volatile organic compounds associated with the disease Rowan DunneMarch 25, 2025
Health and Safety Five startups taking aim at cancer diagnosis and treatment Statistics Canada reports that lung cancer was the leading cause for both men and women Joseph MortonMarch 21, 2025
AI and Autonomy Baird Medical Investment wins award for its cancer-surgery robot The robot will provide end-to-end intelligent automation, using AI-driven precision to integrate preoperative 3D lesion segmentation Joseph MortonMarch 19, 2025
Medical and Pharmaceutical Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump The deal could provide shareholders with an extra $0.70 per share if company's drug gains regulatory approval in Europe Joseph MortonMarch 10, 2025